Research interests include Pharmacogenetics and Drug Metabolism, Genomics and Rare Diseases, Schizophrenia research and treatment, and Computational Drug Discovery Methods.
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study